Arcoma AB Statistics
Total Valuation
Arcoma AB has a market cap or net worth of SEK 120.19 million. The enterprise value is 84.87 million.
| Market Cap | 120.19M |
| Enterprise Value | 84.87M |
Important Dates
The next confirmed earnings date is Tuesday, April 14, 2026.
| Earnings Date | Apr 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Arcoma AB has 14.31 million shares outstanding. The number of shares has increased by 8.99% in one year.
| Current Share Class | 14.31M |
| Shares Outstanding | 14.31M |
| Shares Change (YoY) | +8.99% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.26% |
| Owned by Institutions (%) | n/a |
| Float | 11.93M |
Valuation Ratios
The trailing PE ratio is 24.00 and the forward PE ratio is 13.33.
| PE Ratio | 24.00 |
| Forward PE | 13.33 |
| PS Ratio | 0.92 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | 6.50 |
| P/OCF Ratio | 6.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.25, with an EV/FCF ratio of 4.59.
| EV / Earnings | 16.87 |
| EV / Sales | 0.65 |
| EV / EBITDA | 6.25 |
| EV / EBIT | 13.61 |
| EV / FCF | 4.59 |
Financial Position
The company has a current ratio of 3.49
| Current Ratio | 3.49 |
| Quick Ratio | 2.30 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 52.85 |
Financial Efficiency
Return on equity (ROE) is 7.50% and return on invested capital (ROIC) is 11.19%.
| Return on Equity (ROE) | 7.50% |
| Return on Assets (ROA) | 4.40% |
| Return on Invested Capital (ROIC) | 11.19% |
| Return on Capital Employed (ROCE) | 8.35% |
| Weighted Average Cost of Capital (WACC) | 7.88% |
| Revenue Per Employee | 4.22M |
| Profits Per Employee | 162,258 |
| Employee Count | 31 |
| Asset Turnover | 1.48 |
| Inventory Turnover | 3.26 |
Taxes
In the past 12 months, Arcoma AB has paid 1.28 million in taxes.
| Income Tax | 1.28M |
| Effective Tax Rate | 20.23% |
Stock Price Statistics
The stock price has decreased by -19.62% in the last 52 weeks. The beta is 0.66, so Arcoma AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -19.62% |
| 50-Day Moving Average | 7.79 |
| 200-Day Moving Average | 8.51 |
| Relative Strength Index (RSI) | 54.50 |
| Average Volume (20 Days) | 11,019 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Arcoma AB had revenue of SEK 130.80 million and earned 5.03 million in profits. Earnings per share was 0.35.
| Revenue | 130.80M |
| Gross Profit | 53.27M |
| Operating Income | 6.24M |
| Pretax Income | 6.31M |
| Net Income | 5.03M |
| EBITDA | 13.58M |
| EBIT | 6.24M |
| Earnings Per Share (EPS) | 0.35 |
Balance Sheet
The company has 35.32 million in cash and n/a in debt, with a net cash position of 35.32 million or 2.47 per share.
| Cash & Cash Equivalents | 35.32M |
| Total Debt | n/a |
| Net Cash | 35.32M |
| Net Cash Per Share | 2.47 |
| Equity (Book Value) | 74.73M |
| Book Value Per Share | 5.22 |
| Working Capital | 54.64M |
Cash Flow
In the last 12 months, operating cash flow was 18.72 million and capital expenditures -215,000, giving a free cash flow of 18.51 million.
| Operating Cash Flow | 18.72M |
| Capital Expenditures | -215,000 |
| Depreciation & Amortization | 7.34M |
| Net Borrowing | n/a |
| Free Cash Flow | 18.51M |
| FCF Per Share | 1.29 |
Margins
Gross margin is 40.73%, with operating and profit margins of 4.77% and 3.85%.
| Gross Margin | 40.73% |
| Operating Margin | 4.77% |
| Pretax Margin | 4.82% |
| Profit Margin | 3.85% |
| EBITDA Margin | 10.38% |
| EBIT Margin | 4.77% |
| FCF Margin | 14.15% |
Dividends & Yields
Arcoma AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.99% |
| Shareholder Yield | -8.99% |
| Earnings Yield | 4.18% |
| FCF Yield | 15.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |